Gabelli & Co Investment Advisers’s Verona Pharma VRNA Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-265,266	Closed	-$28.3M	–	326
2025 Q3	$28.3M	Buy	+265,266	New	+$27.7M	4.54%	2

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Gabelli & Co Investment Advisers's VRNA Position: Q4 2025 in Review

Gabelli & Co Investment Advisers sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 265,266 shares — an estimated $28.3M sold.

Gabelli & Co Investment Advisers first reported a position in VRNA in Q3 2025 and held it in 1 quarter. The position peaked at $28.3M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Gabelli & Co Investment Advisers reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 265,266 Verona Pharma shares in Q4 2025, an estimated $28.3M.
Gabelli & Co Investment Advisers first reported a position in Verona Pharma in Q3 2025 and held it in 1 quarter.
Gabelli & Co Investment Advisers's Verona Pharma position peaked at $28.3M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Gabelli & Co Investment Advisers's 13F filing for Q4 2025, filed 5 Feb 2026.